A Novel Use of Specialized Pro-Resolving Mediators to Treat Glaucoma

Principal Investigator
Kinsang Cho, PhD
Schepens Eye Research Institute of Massachusetts Eye and Ear
Boston, MA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$180,000
Active Dates
September 01, 2020 - August 31, 2023
Grant ID
G2020333
Goals
Continuous degeneration of vision is not uncommon in glaucoma patients; despite the intraocular pressure maintaining normal levels. Among various types of immune cells, microglial activation has been known as an early responsive immune cell in glaucoma disease. Recently, unsaturated fatty acids, such as docosahexaenoic acid (DHA) and arachidonic acid (ARA)-derived specialized pro-resolving mediators have been shown to resolve inflammation and protect against neuronal death in neurodegenerative diseases such as Alzheimer’s disease and spinal cord injury. In this proposal, we will investigate the role of DHA-derived specialized pro-resolving mediators in suppressing microglial activation, promoting neuronal survival and vision in mouse models of glaucoma.
Summary
Glaucoma is the second leading cause of blindness. This study aims to identify a novel molecule that would suppress immune inflammation and lead to protect the retinal ganglion cells from death and preserve vision. Further, this study will identify potent specialized pro-resolving mediators that would suppress neuroinflammation and investigate its neuroprotection effect in mouse models of glaucoma. The proposed study will shed light on the development of a novel approach to treat glaucoma.
Related Grants
National Glaucoma Research
Human Retinal Regeneration to Cure Glaucoma
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Karl Wahlin, PhD
Current Organization
University of California, San Diego
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
National Glaucoma Research
Why Certain Retina Ganglion Cells Stay Strong in Glaucoma
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Mengya Zhao, PhD
Current Organization
University of California, San Francisco